180 related articles for article (PubMed ID: 36532079)
1. Autologous bone marrow-derived MSCs engineered to express oFVIII-FLAG engraft in adult sheep and produce an effective increase in plasma FVIII levels.
Trevisan B; Rodriguez M; Medder H; Lankford S; Combs R; Owen J; Atala A; Porada CD; Almeida-Porada G
Front Immunol; 2022; 13():1070476. PubMed ID: 36532079
[TBL] [Abstract][Full Text] [Related]
2. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A.
Kumar P; Gao K; Wang C; Pivetti C; Lankford L; Farmer D; Wang A
Cell Transplant; 2018 Jan; 27(1):130-139. PubMed ID: 29562772
[TBL] [Abstract][Full Text] [Related]
3. Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity.
Rodriguez M; Trevisan B; Ramamurthy RM; George SK; Diaz J; Alexander J; Meares D; Schwahn DJ; Quilici DR; Figueroa J; Gautreaux M; Farland A; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
Nat Commun; 2023 Jul; 14(1):4206. PubMed ID: 37452013
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal cells as targets for gene therapy of hemophilia A.
Chuah MK; Brems H; Vanslembrouck V; Collen D; VandenDriessche T
Hum Gene Ther; 1998 Feb; 9(3):353-65. PubMed ID: 9508053
[TBL] [Abstract][Full Text] [Related]
5. Durable engraftment of genetically modified FVIII-secreting autologous bone marrow stromal cells in the intramedullary microenvironment.
Lee SS; Sivalingam J; Nirmal AJ; Ng WH; Kee I; Song IC; Kiong CY; Gales KA; Chua F; Pena EM; Ogden BE; Kon OL
J Cell Mol Med; 2018 Jul; 22(7):3698-3702. PubMed ID: 29682884
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice.
Kashiwakura Y; Ohmori T; Mimuro J; Yasumoto A; Ishiwata A; Sakata A; Madoiwa S; Inoue M; Hasegawa M; Ozawa K; Sakata Y
J Thromb Haemost; 2012 Sep; 10(9):1802-13. PubMed ID: 22784361
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T
Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785
[TBL] [Abstract][Full Text] [Related]
8. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
Doering CB
Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
[TBL] [Abstract][Full Text] [Related]
9. Role of bone marrow transplantation for correcting hemophilia A in mice.
Follenzi A; Raut S; Merlin S; Sarkar R; Gupta S
Blood; 2012 Jun; 119(23):5532-42. PubMed ID: 22368271
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.
Ramamurthy RM; Rodriguez M; Ainsworth HC; Shields J; Meares D; Bishop C; Farland A; Langefeld CD; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
Front Immunol; 2022; 13():954984. PubMed ID: 36591257
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
Chuah MK; Van Damme A; Zwinnen H; Goovaerts I; Vanslembrouck V; Collen D; VandenDriessche T
Hum Gene Ther; 2000 Mar; 11(5):729-38. PubMed ID: 10757352
[TBL] [Abstract][Full Text] [Related]
13. In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A.
Hemşinlioğlu C; Aslan ES; Taştan C; Çakırsoy D; Turan RD; Seyis U; Elek M; Sır Karakuş G; Günaydın ÖS; Abanuz S; Kançağı DD; Yurtsever B; Yalçın K; Kasap M; Ovalı E
Turk J Haematol; 2023 May; 40(2):118-124. PubMed ID: 37022209
[TBL] [Abstract][Full Text] [Related]
14. The mesenchymal stem cells derived from transgenic mice carrying human coagulation factor VIII can correct phenotype in hemophilia A mice.
Wang Q; Gong X; Gong Z; Ren X; Ren Z; Huang S; Zeng Y
J Genet Genomics; 2013 Dec; 40(12):617-28. PubMed ID: 24377868
[TBL] [Abstract][Full Text] [Related]
15. In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment.
Kao YT; Yen CC; Fan HC; Chen JK; Chen MS; Lan YW; Yang SH; Chen CM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003601
[TBL] [Abstract][Full Text] [Related]
16. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of
Zhao J; Zhou M; Wang Z; Wu L; Hu Z; Liang D
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054807
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of recombinant ovine coagulation factor VIII.
Zakas PM; Gangadharan B; Almeida-Porada G; Porada CD; Spencer HT; Doering CB
PLoS One; 2012; 7(11):e49481. PubMed ID: 23152911
[TBL] [Abstract][Full Text] [Related]
18. High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells.
Gangadharan B; Parker ET; Ide LM; Spencer HT; Doering CB
Blood; 2006 May; 107(10):3859-64. PubMed ID: 16449528
[TBL] [Abstract][Full Text] [Related]
19. Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
Moayeri M; Hawley TS; Hawley RG
Mol Ther; 2005 Dec; 12(6):1034-42. PubMed ID: 16226058
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
